Review on Drug induced hematological disorder.
Abstract
Keywords
Full Text:
PDFReferences
Lubran, MICHAEL M. "Hematologic side effects of drugs." Annals of Clinical & Laboratory Science 19.2 (1989): 114-121.
Scheinberg, Phillip, and Neal S. Young. "How I treat acquired aplastic anemia." Blood, The Journal of the American Society of Hematology 120.6 (2012): 1185-1196.
Brodsky, Robert A., and Richard J. Jones. "Aplastic anaemia." The Lancet 365, no. 9471 (2005): 1647-165.
A M Gewirtz, R Hoffman. Current considerations of the etiology of aplastic anemia. Crit Rev Oncol Hematol 1985; 4:1–30.
N S Young, R T Calado, and P Scheinberg. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006; 108: 2509–19.
Roger Walker. Clinical Pharmacy and Therapeutics. 2012; 5th edition: 655-663.
G. Garratty and P. A. Arndt, An update on drug-induced immune hemolyticanemia, Immunohematology, 2007; 23(2): 105–119.
Amit Kumar, V N Jha and Nimisha. Megaloblastic Anemia – An Underdiagnosed Public Health Problem. World Journal of Pharmaceutical and Medical Research 2018,4(2), 100-101
K C Das, Das Monisha and D Mohanty, M.M Jadaon, A Gupta Megaloblastosis: from morphos tomolecules. Med PrincPract 2005; 14: (Suppl 1): 2-14.
N L Kobrinsky and N K Ramsay. Acute megaloblastic anemia induced by high-dose trimethoprim-sulfamethoxazole. Ann Intern Med 1981; 94: 780- 781.
F Magee, O’H Sullivan and S R McCann. Megaloblastosis and lowdose trimethoprim-sulfamethoxazole. Ann Intern Med 1981; 95: 657-661.
N Patel, H Vandewall, and L Tristani. A comparative evaluation of adverse platelet outcomes among Veterans’ Affairs patients receiving linezolid or vancomycin. J AntimicrobChemother 2012;67(3):725–735 13.N.James George and H Richard. AsterDruginduced thrombocyte-penia: pathogenesis, evaluation, and management. Hematology (Am SocHematolEduc Program) 2009: 153– 158
B Kenney and Stack G. Drug-induced thrombocytopenia. Arch Pathol Lab Med 2009; 133(2): 309–31
N Frickhofen, Z J Chen, N S Young, B J Cohen, H Heimpel and J L Abkowitz. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol. 1994;87(4):818-24.
B Saikia, H Aneja, A Manchanda, R Patowary and B Barman. Carbamazepine-induced Pure Red Cell Aplasia in a Young Girl. Indian Journal of Medical Specialities Trust 2010; 1(2): 130- 133
R A Sharma, P Hiwarkar, M V Manglani and H P Muralidhar. Acquired pure red cell aplasia in a child. J Postgrad Med, 2002; 48: 37-38
Bennett CL, Cournoyer D, Carson KR, Rossert J, Luminari S, Evens AM, Locatelli F, Belknap SM, McKoy JM, Lyons EA, Kim B. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood. 2005 Nov 15;106(10):3343-7.6.
Topal, Hatice, and Yasar Topal. "Toxic methemoglobinemia treated with ascorbic acid: Case report." Iranian Red Crescent Medical Journal 15, no. 12 (2013).
Alcindor, Thierry, and Kenneth R. Bridges. "Sideroblastic anaemias." British journal of haematology 116, no. 4 (2002): 733-743.
R. A. Sharp, J. G. Lowe and R. N. Johnston, “Anti-tuberculousdrugs and sideroblastic anaemia,” British Journal of Clinical Practice, 1990; 44 (12). 7 06–707.
S Ammus and A A.Yunis. Druginduced red cell dyscrasias.Blood Rev. 1989;3(2):71-82.
L A Fernandez and E Zayed.Busulfan-induced sideroblasticanemia. Am J Hematol. 1988; 28(3):199–200.
L Kandola, A J Swannell, and A HunterAcquired sideroblastic anaemia associated with penicillamine therapy for rheumatoid arthritis.Ann Rheum Dis. 1995; 54(6): 529–530.
DOI: https://doi.org/10.37591/rrjodfdp.v10i2.1344
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Research & Reviews: A Journal of Drug Formulation, Development and Production